This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Express Scripts (ESRX)

NASDAQ: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 104.10B 93.86B 46.13B 44.97B
Cost of Sales 93.52B 84.66B 42.66B 41.77B
Gross Operating Profit 10.58B 9.20B 3.46B 3.20B
Selling, General, and Administrative Expenses 4.58B 4.55B 898.20M 887.30M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 6.00B 4.66B 2.57B 2.32B
Depreciation & Amortization 2.45B 1.87B 253.40M 244.70M
Interest Income 41.90M 10.60M 12.40M 4.90M
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 3.63B 2.81B 2.32B 2.08B
Interest Expense 596.10M 619.00M 299.70M 167.10M
Pre-Tax Income 3.03B 2.19B 2.02B 1.91B
Income Taxes 1.10B 833.30M 748.60M 704.10M
Minority Interest 28.10M 17.20M 0.00 0.00
Net Income From Continuing Operations 1.93B 1.36B 1.28B 1.20B
Net Income From Discontinued Operations -53.60M -27.60M 0.00 -23.40M
Net Income From Total Operations 1.87B 1.33B 1.28B 1.18B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.84B 1.31B 1.28B 1.18B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.93B 1.36B 1.28B 1.20B
Preferred Dividends
Net Income Available To Common 1.93B 1.36B 1.28B 1.20B
Basic EPS from Continuing Ops. 2.35 1.83 2.55 2.24
Basic EPS from Discontinued Ops. -0.07 -0.04 0.00 -0.04
Basic EPS from Total Operations 2.28 1.79 2.55 2.20
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.01 0.00 -0.01
Basic EPS, Total 2.28 1.80 2.55 2.19
Basic Normalized Net Income/Share 2.35 1.83 2.55 2.24
EPS fr Continuing Ops. 2.31 1.79 2.53 2.21
EPS fr Discontinued Ops -0.07 -0.04 0.00 -0.04
EPS fr Total Ops. 2.24 1.75 2.53 2.17
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.01 0.01 0.00 0.00
EPS, Total 2.25 1.76 2.53 2.17
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.31 1.79 2.53 2.21
Dividends Paid per Share 0.00 0.00 0.00 0.00
ESRX News

ESRX Express Scripts

Analysts Ratings for ESRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 12 13 12
Moderate Buy 2 2 2 2
Hold 4 5 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ESRX ANALYST REPORT

Brokerage Partners

ESRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs